Objective: Pharmacologic cardiac stress SPECT (PS-SPECT) has been commonly used test for non-invasive evaluation of ischaemic heart disease (IHD) in patients unable to exercise. New techniques (like cardiac CT-scan) are replacing its use in many clinical scenarios and scientific publications. However, it is still the only available test for non-invasive evaluation of some patients in many hospitals. The aim of the study was to evaluate the prognostic value of PS-SPECT currently.
Materials and methods:Retrospective study of 1,214 patients referred for PS-SPECT between 2010 and 2016 who completed a median follow-up of 3 years. Patients had a median age of 74 ±1 0 years, 56% were women, and had high prevalence of cardiovascular risk factors -diabetes (51%); arterial hypertension (86%); hypercholesterolaemia (60%); chronic IHD (38%) or peripheral artery disease (44%). Dipyridamole was the drug used for stress in 89% of cases.Results: 41% of the patients presented moderate or severe ischemia (MS-ISC) whereas 46% of patients had normal perfusion (NP). Global mortality was high at 1 year (5.5%) and at long-term follow-up (26.5%), and was significantly lower (p<0.001) for patients with NP both at first year (3%) and at the end of follow-up (19.6%). Patients with MS-ISC had highest mortality at 1 year (8.6%, p=0.065) and at long-term follow-up (42.6%, p<0.001).
Conclusion:PS-SPECT is still a valuable prognostic tool for patients with suspected IHD unable to exercise. Even in high-risk populations, the presence of MS-ISC and NP identifies those patients with the highest and lowest mortality risk, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.